Evidence map›Paper›PMID 29156133›Full record

ArticleACS nano2017

Harnessing Sphingosine-1-Phosphate Signaling and Nanotopographical Cues To Regulate Skeletal Muscle Maturation and Vascularization.

Jonathan H Tsui, Kajohnkiart Janebodin, Nicholas Ieronimakis, David M P Yama, Hee Seok Yang, Rakchanok Chavanachat, Aislinn L Hays, Haeshin Lee, Morayma Reyes, Deok-Ho Kim

Abstract read
In one paragraph

Article in ACS nano, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. iPSCs: A powerful tool for skeletal muscle tissue engineering.Journal of cellular and molecular medicine · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonathan H Tsui
Kajohnkiart JanebodinDepartment of Anatomy, Faculty of Dentistry, Mahidol University , Bangkok 73170, Thailand.
Nicholas IeronimakisDepartment of Clinical Investigation, Madigan Army Medical Center , Tacoma, Washington 98431, United States.
David M P Yama
Hee Seok YangDepartment of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University , Cheonan, South Korea.
Rakchanok Chavanachat
Aislinn L HaysDepartment of Pathology, Albert Einstein College of Medicine , Bronx, New York 10467, United States.
Haeshin LeeDepartment of Chemistry and the Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology , Daejeon, South Korea.ORCID 0000-0003-3961-9727
Morayma ReyesDepartment of Pathology, Albert Einstein College of Medicine , Bronx, New York 10467, United States.

Funding

SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI PRUSKY, GLEN THOMAS · 1985 to 2021
$29.6M
Surface Analysis Facility for Biomedical ProblemsP41EB002027 · NIBIB · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2003 to 2019
$17.6M
GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHYR01NS094388 · NINDS · UNIVERSITY OF WASHINGTON · PI KIM, DEOK-HO · 2017 to 2021
$1.7M
Nanopatterned 3D Vascularized Functional Muscle PatchR21AR064395 · NIAMS · UNIVERSITY OF WASHINGTON · PI KIM, DEOK-HO · 2014 to 2015
$421k
NIAMS NIH HHS R21 AR064395NIA NIH HHS P01 AG001751NIA NIH HHS T32 AG000057NIBIB NIH HHS P41 EB002027NINDS NIH HHS R01 NS094388
6 · The paper itself

Abstract

Despite possessing substantial regenerative capacity, skeletal muscle can suffer from loss of function due to catastrophic traumatic injury or degenerative disease. In such cases, engineered tissue grafts hold the potential to restore function and improve patient quality of life. Requirements for successful integration of engineered tissue grafts with the host musculature include cell alignment that mimics host tissue architecture and directional functionality, as well as vascularization to ensure tissue survival. Here, we have developed biomimetic nanopatterned poly(lactic-co-glycolic acid) substrates conjugated with sphingosine-1-phosphate (S1P), a potent angiogenic and myogenic factor, to enhance myoblast and endothelial maturation. Primary muscle cells cultured on these functionalized S1P nanopatterned substrates developed a highly aligned and elongated morphology and exhibited higher expression levels of myosin heavy chain, in addition to genes characteristic of mature skeletal muscle. We also found that S1P enhanced angiogenic potential in these cultures, as evidenced by elevated expression of endothelial-related genes. Computational analyses of live-cell videos showed a significantly improved functionality of tissues cultured on S1P-functionalized nanopatterns as indicated by greater myotube contraction displacements and velocities. In summary, our study demonstrates that biomimetic nanotopography and S1P can be combined to synergistically regulate the maturation and vascularization of engineered skeletal muscles.

Indexed as

NanotechnologySignal TransductionAnimalsBiomimetic MaterialsCell DifferentiationCells, CulturedDose-Response Relationship, DrugEndothelial CellsLysophospholipidsMiceMice, KnockoutMice, TransgenicMuscle, SkeletalNanoparticlesNeovascularization, PathologicPolylactic Acid-Polyglycolic Acid CopolymerLysophospholipidsPolylactic Acid-Polyglycolic Acid CopolymerSphingosinesphingosine 1-phosphatenanotopographyskeletal musclesphingosine-1-phosphatetissue engineeringvascularization

Identifiers

PMID29156133
PMCPMC6133580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.